![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
RE West , A Zweig, NY Shih, MI Siegel, RW Egan and MA Clark
Department of Allergy and Immunology, Schering-Plough Research, Bloomfield, New Jersey 07003.
The H3-histamine receptor provides feedback inhibition of histamine synthesis and release as well as inhibition of other neurotransmitter release. We have characterized this receptor by radioligand binding studies with the H3 agonist N alpha-[3H]methylhistamine ([3H]NAMHA). The results of [3H]NAMHA saturation binding and NAMHA inhibition of [3H]NAMHA binding were consistent with an apparently single class of receptors (KD = 0.37 nM, Bmax = 73 fmol/mg of protein) and competition assays with other agonists and the antagonists impromidine and dimaprit disclosed only a single class of sites. In contrast, inhibition of [3H]NAMHA binding by the specific high affinity H3 antagonist thioperamide revealed two classes of sites (KiA = 5 nM, BmaxA = 30 fmol/mg of protein; KiB = 68 nM, BmaxB = 48 fmol/mg of protein). Burimamide, another antagonist that, like thioperamide, contains a thiourea group, likewise discriminated between two classes of sites. In addition to differences between some antagonist potencies for the two receptors, there is a differential guanine nucleotide sensitivity of the two. The affinity of the H3A receptor for [3H] NAMHA was reduced less than 2-fold, whereas [3H]NAMHA binding to the H3B receptor was undetectable in the presence of guanosine 5'-O-(3-thiotriphosphate). The distinction between H3A and H3B receptor subtypes, the former a high affinity and the latter a low affinity thioperamide site, draws support from published in vitro data.
This article has been cited by other articles:
|
|
 |
|
  T.-K. Kukko-Lukjanov, S. Soini, T. Taira, K. A. Michelsen, P. Panula, and I. E. Holopainen Histaminergic Neurons Protect the Developing Hippocampus from Kainic Acid-Induced Neuronal Damage in an Organotypic Coculture System J. Neurosci., January 25, 2006; 26(4): 1088 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Mcleod, C. A. Rizzo, R. E. West Jr., R. Aslanian, K. Mccormick, M. Bryant, Y. Hsieh, W. Korfmacher, G. G. Mingo, L. Varty, et al. J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1037 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Toyota, C. Dugovic, M. Koehl, A. D. Laposky, C. Weber, K. Ngo, Y. Wu, D. H. Lee, K. Yanai, E. Sakurai, et al. Behavioral Characterization of Mice Lacking Histamine H3 Receptors Mol. Pharmacol., August 1, 2002; 62(2): 389 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nguyen, D. A. Shapiro, S. R. George, V. Setola, D. K. Lee, R. Cheng, L. Rauser, S. P. Lee, K. R. Lynch, B. L. Roth, et al. Discovery of a Novel Member of the Histamine Receptor Family Mol. Pharmacol., March 1, 2001; 59(3): 427 - 433. [Abstract] [Full Text]
|
|
|
|
|
|
G. Drutel, N. Peitsaro, K. Karlstedt, K. Wieland, M. J. Smit, H. Timmerman, P. Panula, and R. Leurs Identification of Rat H3 Receptor Isoforms with Different Brain Expression and Signaling Properties Mol. Pharmacol., January 1, 2001; 59(1): 1 - 8. [Abstract] [Full Text]
|
|
|
|
|
|
T. W. Lovenberg, J. Pyati, H. Chang, S. J. Wilson, and M. G. Erlander Cloning of Rat Histamine H3 Receptor Reveals Distinct Species Pharmacological Profiles J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 771 - 778. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Sirois, G. Menard, A. S. Moses, and E. Y. Bissonnette Importance of Histamine in the Cytokine Network in the Lung Through H2 and H3 Receptors: Stimulation of IL-10 Production J. Immunol., March 15, 2000; 164(6): 2964 - 2970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Rozniecki, R. Letourneau, M. Sugiultzoglu, C. Spanos, J. Gorbach, and T. C. Theoharides Differential Effect of Histamine 3 Receptor-Active Agents on Brain, but not Peritoneal, Mast Cell Activation J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1427 - 1435. [Abstract] [Full Text]
|
|
|
|
|
|
T. W. Lovenberg, B. L. Roland, S. J. Wilson, X. Jiang, J. Pyati, A. Huvar, M. R. Jackson, and M. G. Erlander ACCELERATED COMMUNICATION: Cloning and Functional Expression of the Human Histamine H3 Receptor Mol. Pharmacol., June 1, 1999; 55(6): 1101 - 1107. [Abstract] [Full Text]
|
|
|
|
|
|
C. E. Tedford, J. G. Phillips, R. Gregory, G. P. Pawlowski, L. Fadnis, M. A. Khan, S. M. Ali, M. K. Handley, and S. L. Yates Development of trans-2-[1H-Imidazol-4-yl] Cyclopropane Derivatives as New High-Affinity Histamine H3 Receptor Ligands J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 1160 - 1168. [Abstract] [Full Text]
|
|
|
|
|
|
L. B. Hough, J. W. Nalwalk, B. Y. Li, R. Leurs, W.M.P.B. Menge, H. Timmerman, M. E. Carlile, C. Cioffi, and M. Wentland Novel Qualitative Structure-Activity Relationships for the Antinociceptive Actions of H2 Antagonists, H3 Antagonists and Derivatives J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1534 - 1543. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. J. Hill, C. R. Ganellin, H. Timmerman, J. C. Schwartz, N. P. Shankley, J. M. Young, W. Schunack, R. Levi, and H. L. Haas International Union of Pharmacology. XIII. Classification of Histamine Receptors Pharmacol. Rev., September 1, 1997; 49(3): 253 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. E. Shannon, M. J. Sheardown, F. P. Bymaster, D. O. Calligaro, N. W. Delapp, J. Gidda, C. H. Mitch, B. D. Sawyer, P. W. Stengel, J. S. Ward, et al. Pharmacology of Butylthio[2.2.2] (LY297802/NNC11-1053): A Novel Analgesic with Mixed Muscarinic Receptor Agonist and Antagonist Activity J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 884 - 894. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Imamura, H. M. Lander, and R. Levi Activation of Histamine H3-Receptors Inhibits Carrier-Mediated Norepinephrine Release During Protracted Myocardial Ischemia : Comparison With Adenosine A1-Receptors and {alpha}2-Adrenoceptors Circ. Res., March 1, 1996; 78(3): 475 - 481. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Oda, N. Morikawa, Y. Saito, Y. Masuho, and S.-i. Matsumoto Molecular Cloning and Characterization of a Novel Type of Histamine Receptor Preferentially Expressed in Leukocytes J. Biol. Chem., November 17, 2000; 275(47): 36781 - 36786. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
